A new release, 3.14.1 IDNS^®, introduces new SmartGene Apps for HSV-1, HSV-2, and CMV drug resistance analysis.

The HSV App supports SNP detection and antiviral resistance assessment for UL5, UL8, UL23, UL30, and UL52, while the CMV App covers UL27, UL51, UL54, UL56, UL89, and UL97.

By rapidly and accurately interpreting clinically relevant mutations, SmartGene provides clinicians with clear, evidence-based guidance for antiviral therapy selection.

SmartGene transforms raw sequencing data into actionable results without requiring bioinformatics expertise or local IT infrastructure. All SmartGene Apps are compatible with leading sequencing platforms and support both Sanger (.ab1) and NGS (FASTQ) data. Integrated reporting, searchable archives, and streamlined workflows help laboratories deliver results quickly and confidently.